De Berardis, D.; Marini, S.; Fornaro, M.; Srinivasan, V.; Iasevoli, F.; Tomasetti, C.; Valchera, A.; Perna, G.; Quera-Salva, M.-A.; Martinotti, G.;
et al. The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice. Int. J. Mol. Sci. 2013, 14, 12458-12483.
https://doi.org/10.3390/ijms140612458
AMA Style
De Berardis D, Marini S, Fornaro M, Srinivasan V, Iasevoli F, Tomasetti C, Valchera A, Perna G, Quera-Salva M-A, Martinotti G,
et al. The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice. International Journal of Molecular Sciences. 2013; 14(6):12458-12483.
https://doi.org/10.3390/ijms140612458
Chicago/Turabian Style
De Berardis, Domenico, Stefano Marini, Michele Fornaro, Venkataramanujam Srinivasan, Felice Iasevoli, Carmine Tomasetti, Alessandro Valchera, Giampaolo Perna, Maria-Antonia Quera-Salva, Giovanni Martinotti,
and et al. 2013. "The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice" International Journal of Molecular Sciences 14, no. 6: 12458-12483.
https://doi.org/10.3390/ijms140612458
APA Style
De Berardis, D., Marini, S., Fornaro, M., Srinivasan, V., Iasevoli, F., Tomasetti, C., Valchera, A., Perna, G., Quera-Salva, M.-A., Martinotti, G., & Di Giannantonio, M.
(2013). The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice. International Journal of Molecular Sciences, 14(6), 12458-12483.
https://doi.org/10.3390/ijms140612458